Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ACPH.BR Stock Summary
In the News
ACPH.BR Financial details
Company Rating
Neutral
Market Cap
0
Income
-17.07M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
76
Optionable
No
Shortable
Yes
Earnings
31 Mar 2022
P/E
-1.16
Forward P/E
-
PEG
0.17
P/S
-
P/B
3
P/C
-
P/FCF
-
Quick Ratio
2.62
Current Ratio
3.79
Debt / Equity
1.08
LT Debt / Equity
1.08
-
-
EPS (TTM)
-0.19
EPS next Y
-
EPS next Q
-
EPS this Y
35.48%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
19.68%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-108%
ROE
-155%
ROC
-1.2%
Gross Margin
75%
Oper. Margin
-5561%
Profit Margin
-5767%
Payout
-
Shs Outstand
100.94M
Shs Float
51.23M
-
-
-
-
Target Price
-
52W Range
0.876-0.89
52W High
-
52W Low
-
RSI
-
Rel Volume
1.89
Avg Volume
402.31K
Volume
761.38K
Perf Week
0%
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
1.78911
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.888
Change
-
ACPH.BR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0.01 | |
Net income per share | -0.16 | -0.45 | -0.43 | -0.62 | -0.84 | |
Operating cash flow per share | -0.1 | -0.34 | -0.37 | -0.47 | -0.56 | |
Free cash flow per share | -0.1 | -0.34 | -0.37 | -0.47 | -0.56 | |
Cash per share | 0.08 | 0.84 | 0.32 | 0.87 | 0.27 | |
Book value per share | -0.45 | 0.56 | 0.08 | 1.13 | 0.32 | |
Tangible book value per share | -0.45 | 0.56 | 0.08 | 0.15 | -0.06 | |
Share holders equity per share | -0.45 | 0.56 | 0.08 | 1.13 | 0.32 | |
Interest debt per share | 0.27 | 0.26 | 0.21 | 0.72 | 0.39 | |
Market cap | 41.78M | 35.29M | 40.72M | 43.01M | 59.47M | |
Enterprise value | 50.09M | 7.31M | 33.59M | 32.82M | 65.88M | |
P/E ratio | -5.01 | -1.79 | -1.78 | -1.28 | -0.89 | |
Price to sales ratio | 0 | 0 | 0 | 203.86 | 51.14 | |
POCF ratio | -8.25 | -2.39 | -2.05 | -1.7 | -1.33 | |
PFCF ratio | -8.25 | -2.39 | -2.05 | -1.7 | -1.33 | |
P/B Ratio | -1.74 | 1.44 | 9.37 | 0.71 | 2.3 | |
PTB ratio | -1.74 | 1.44 | 9.37 | 0.71 | 2.3 | |
EV to sales | 0 | 0 | 0 | 155.57 | 56.65 | |
Enterprise value over EBITDA | -7.39 | -0.4 | -1.53 | -1.14 | -1.17 | |
EV to operating cash flow | -9.89 | -0.49 | -1.69 | -1.29 | -1.48 | |
EV to free cash flow | -9.89 | -0.49 | -1.69 | -1.29 | -1.48 | |
Earnings yield | -0.2 | -0.56 | -0.56 | -0.78 | -1.13 | |
Free cash flow yield | -0.12 | -0.42 | -0.49 | -0.59 | -0.75 | |
Debt to equity | -0.52 | 0.38 | 2.27 | 0.6 | 1.08 | |
Debt to assets | 2.58 | 0.24 | 0.53 | 0.35 | 0.45 | |
Net debt to EBITDA | -1.23 | 1.54 | 0.33 | 0.35 | -0.11 | |
Current ratio | 0.17 | 7.48 | 1.9 | 4.55 | 3.79 | |
Interest coverage | -2 | -8.08 | -15.05 | -14.12 | -19.38 | |
Income quality | 0.61 | 0.75 | 0.87 | 0.76 | 0.66 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 54.82 | 15.5 | |
Research and developement to revenue | 0 | 0 | 0 | 0.47 | 3.5 | |
Intangibles to total assets | 0 | 0 | 0 | 0.51 | 0.49 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 12.77 | 3.29 | |
Graham number | 1.27 | 2.36 | 0.88 | 3.98 | 2.47 | |
ROIC | 0.33 | -0.54 | -1.49 | -0.31 | -1.18 | |
Return on tangible assets | -1.73 | -0.51 | -1.22 | -0.66 | -2.14 | |
Graham Net | -0.47 | 0.53 | 0.05 | 0.11 | -0.14 | |
Working capital | -24.03M | 33.36M | 8.68M | 39.32M | 22.98M | |
Tangible asset value | -24.03M | 24.52M | 4.35M | 8.32M | -4.74M | |
Net current asset value | -24.03M | 24.52M | 3.98M | 8.04M | -4.92M | |
Invested capital | -0.52 | 0.38 | 2.27 | 0.6 | 1.08 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 3.85M | 1.24M | 1.89M | 1.9M | 1.95M | |
Average inventory | 0 | 0 | 0 | 1.33M | 4.77M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 14.4K | 3.41K | |
Days of inventory on hand | 0 | 0 | 0 | 33.5K | 8.5K | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0.03 | 0.11 | |
Inventory turnover | 0 | 0 | 0 | 0.01 | 0.04 | |
ROE | 0.35 | -0.8 | -5.25 | -0.55 | -2.59 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2021-12-31 for Q4
Metric | History | 2019-12-31 | 2020-06-30 | 2020-12-31 | 2021-06-30 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -7.13M | -16.71M | -10.19M | -17.55M | 6.41M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 2.27 | 0.31 | 0.6 | 0.45 | 1.08 | |
Debt to assets | 0.53 | 0.21 | 0.35 | 0.29 | 0.45 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.9 | 2.97 | 4.55 | 7.13 | 3.79 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.3 | 0.51 | 0 | 0.49 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 8.68M | 16.94M | 39.32M | 46M | 22.98M | |
Tangible asset value | 4.35M | 14.54M | 8.32M | 65.57M | -4.74M | |
Net current asset value | 3.98M | 14.22M | 8.04M | 16.54M | -4.92M | |
Invested capital | 2.27 | 0.31 | 0.6 | 0.45 | 1.08 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ACPH.BR Frequently Asked Questions
What is Acacia Pharma Group plc stock symbol ?
Acacia Pharma Group plc is a GB stock , located in Cambridge of Cambridgeshire and trading under the symbol ACPH.BR
What is Acacia Pharma Group plc stock quote today ?
Acacia Pharma Group plc stock price is $0.888 today.
Is Acacia Pharma Group plc stock public?
Yes, Acacia Pharma Group plc is a publicly traded company.